Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Chella

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
ESMO Open|August 22, 2020
erbB in NSCLC as a molecular target: current evidences and future directionsMarzia Del Re, Federico Cucchiara, Iacopo Petrini, et al.
Frontiers in Oncology|June 28, 2021
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell TransformationRossella Bruno, Marzia Del Re, Federico Cucchiara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2013
Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089)Achim Rittmeyer, Vera Gorbunova, Anders Vikström, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 2016
First-line treatment of NSCLC with bevacizumab: real world data from an Italian regional based surveyAndrea Camerini, Antonio Chella, Francesca Mazzoni, et al.
The Journal of Molecular Diagnostics : JMD|February 10, 2020
Differential Diagnosis of Malignant Pleural Mesothelioma on Cytology: A Gene Expression Panel versus BRCA1-Associated Protein 1 and p16 TestsRossella Bruno, Greta Alì, Anello M Poma, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal DiseaseDavid Viola, Carlotta Giani, Salvatore Mazzeo, et al.
Cancer Cytopathology|March 21, 2014
Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessmentAgnese Proietti, Greta Alì, Serena Pelliccioni, et al.
International Journal of Oncology|July 4, 2013
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular featuresAlessandra Capodanno, Laura Boldrini, Agnese Proietti, et al.
Anticancer Research|December 7, 2016
Second-line Erlotinib or Intermittent Erlotinib plus Docetaxel in Male Ex-smokers with Squamous NSCLC: The TALISMAN Randomized TrialCesare Gridelli, Antonio Chella, Giuseppe Valmadre, et al.
Cancers|February 13, 2025
Prognostic Stratification of Epithelioid Pleural Mesothelioma Based on the Hippo-TEADs NetworkAnello Marcello Poma, Rossella Bruno, Iacopo Petrini, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
ESMO Open|August 22, 2020
erbB in NSCLC as a molecular target: current evidences and future directionsMarzia Del Re, Federico Cucchiara, Iacopo Petrini, et al.
Frontiers in Oncology|June 28, 2021
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell TransformationRossella Bruno, Marzia Del Re, Federico Cucchiara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2013
Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089)Achim Rittmeyer, Vera Gorbunova, Anders Vikström, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 2016
First-line treatment of NSCLC with bevacizumab: real world data from an Italian regional based surveyAndrea Camerini, Antonio Chella, Francesca Mazzoni, et al.
The Journal of Molecular Diagnostics : JMD|February 10, 2020
Differential Diagnosis of Malignant Pleural Mesothelioma on Cytology: A Gene Expression Panel versus BRCA1-Associated Protein 1 and p16 TestsRossella Bruno, Greta Alì, Anello M Poma, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal DiseaseDavid Viola, Carlotta Giani, Salvatore Mazzeo, et al.
Cancer Cytopathology|March 21, 2014
Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessmentAgnese Proietti, Greta Alì, Serena Pelliccioni, et al.
International Journal of Oncology|July 4, 2013
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular featuresAlessandra Capodanno, Laura Boldrini, Agnese Proietti, et al.
Anticancer Research|December 7, 2016
Second-line Erlotinib or Intermittent Erlotinib plus Docetaxel in Male Ex-smokers with Squamous NSCLC: The TALISMAN Randomized TrialCesare Gridelli, Antonio Chella, Giuseppe Valmadre, et al.
Cancers|February 13, 2025
Prognostic Stratification of Epithelioid Pleural Mesothelioma Based on the Hippo-TEADs NetworkAnello Marcello Poma, Rossella Bruno, Iacopo Petrini, et al.
Pageof 12